The retinofugal and retinopetal connections of the Pacific hagfish were determined using the fluorescent compound DiI as an in vitro tracer. The retinofugal connections were found to be bilateral and to reach preoptic;, thalamic and pretectal, as well as tectal, targets. No distinct basal optic root was found. A retinopetal projection in hagfishes is described here for the first time. It originates from two cell groups in the rostral mesencephalic tegmentum. These retinal connections in hagfishes are compared to the organization of the visual system in the second Recent group of jawless fishes, the lampreys. Both visual systems are similar in the number and location of the targets of retinal fibers. Furthermore, there is a striking similarity in the retinopetal systems. Major differences are found in the organization of the optic tract. These observations allow the identification of some cell groups not previously recognized in myxinoid brains or interpreted differently. Finally, the findings are discussed in relation to visually guided behavior in hagfishes.

Keywords:
Myxinoidea, Retina, Forebrain, Visual system, Retinofugal connections, Retinopetal connections
This content is only available via PDF.
© 1990 S. Karger AG, Basel
1990
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.